Top-News
Chemikalien Dänemark

Novozymes AS B Aktie

Aktie
WKN:  A1JP9Y ISIN:  DK0060336014 US-Symbol:  NVZMF
58,88 €
+0,3 €
+0,51%
13.05.25
Depot/Watchlist
Marktkapitalisierung *
24,16 Mrd. €
Streubesitz
40,99%
KGV
49,82
Dividende
0,5364 DKK
Dividendenrendite
0,94%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 11.03.2025
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,24: MG2259
Werbung

Novozymes AS B News

08.05.25 - GlobeNewswire
Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook
COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted ...
26.02.25 - GlobeNewswire
12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025
Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an ...
11.02.25 - GlobeNewswire
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
Novonesis has reached an agreement with dsm-​firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash ...
03.12.24 - wallstreetONLINE Redaktion
Tipps für 2025: Goldmans heiße Liste für 2025 – Kursraketen in Sicht!
Goldman Sachs hat seine Liste der besten globalen Aktien aktualisiert, indem einige hinzugefügt und andere entfernt wurden. Dabei sind Kurs-​Knaller mit einem möglichen ...
07.11.24 - GlobeNewswire
Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%
Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third ...
27.08.24 - GlobeNewswire
Novonesis delivers strong half-year results and increases full-year outlook
In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases ...
03.05.24 - GlobeNewswire
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration
For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with ...
01.02.24 - GlobeNewswire
Legacy Novozymes delivers solid last full-year results
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth ...
29.01.24 - GlobeNewswire
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-...
09.12.23 - Aktienwelt360
Talsohle durchschritten: Diese 2 Aktien können derzeit mit einem fantastischen Aufholpotenzial glänzen!
Wieder neigt sich ein ereignisreiches Börsenjahr dem Ende zu. Und so wie es aussieht, werden es die großen Indizes aus Deutschland und den USA mit einem deutlichen Plus ...
09.11.23 - GlobeNewswire
Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment
Novozymes, a global leader in biosolutions, marks a significant milestone in the renewable diesel and SAF (Sustainable Aviation Fuel) industry with the launch of Quara® LowP, an ...
26.10.23 - PR Newswire
Not Just Yogurt Anymore
Not Just Yogurt Anymore PR Newswire
26.10.23 - GlobeNewswire
Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations
After the first nine months of the 2023 financial year, Novozymes sees increasing demand for sustainable biosolutions and delivers 5 % organic sales growth. The full-year organic ...
03.10.23 - PR Newswire
Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row
Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row PR Newswire
09.08.23 - GlobeNewswire
Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook
After the first half of 2023, Novozymes sees overall stability in a volatile environment and delivers 3 % organic sales growth. Following destocking and lower consumer demand, the ...
26.04.23 - GlobeNewswire
Novozymes delivers stronger than expected Q1 results
After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic sales growth. The company confirms the 2023 outlook of 4-7% which is expected ...
30.03.23 - GlobeNewswire
Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
The proposed combination of Novozymes and Chr. Hansen has now been approved by each company’s respective shareholders, and with strong support from the shareholders the ...
26.01.23 - GlobeNewswire
Novozymes delivers historically strong full-year results
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more ...
16.12.22 - Platow
Novozymes macht Quantensprung
In Skandinavien entsteht gerade eine fast märchenhafte Verbindung. Getrieben vom gemeinsamen Anteilseigner Novo Holding schließen sich die beiden hochprofitablen, in sich ...
12.12.22 - dpa-AFX
AKTIEN IM FOKUS: Fusion von Novozymes mit Chr. Hansen treibt Symrise an
Eine Fusion der Enzymspezialisten Novozymes und Chr. Hansen hat am Montag Fantasie in die Branche der Hersteller von Lebensmittelzusätzen gebracht. Insbesondere der Dax-...

Newssuche

Videos

newspaper
13.05.25 +5,09%
Technical Trading: Silber vor Verdopplung
Silber Long Typ: Turbo Open End WKN: VC1HA0 Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
OSZAR »